Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v3.4.0.3
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net earnings (loss) $ 427 $ 19
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]    
Depreciation and amortization 87 84
Stock-based compensation 34 44
Excess tax benefit from stock-based compensation (73) (14)
Share of (earnings) loss of affiliates, net 12 37
Realized and unrealized (gains) losses on financial instruments, net 8 28
Losses (gains) on dilution of investment in affiliate 2 1
Deferred income tax expense (benefit) 114 70
Other, net 3 6
Changes in operating assets and liabilities    
Current and other assets (23) (22)
Payables and other current liabilities 223 62
Net cash provided (used) by operating activities 814 315
Cash flows from investing activities:    
Investments in and loans to cost and equity investees (11)  
Proceeds from Sale of Available-for-sale Securities 2 113
Proceeds (payments) from settlement of financial instruments, net   (17)
Capital expended for property and equipment (67) (64)
Purchases of short term investments and other marketable securities (99) (10)
Sales of short term investments and other marketable securities 53 136
Other investing activities, net (3) (14)
Net cash provided (used) by investing activities (125) 144
Cash flows from financing activities:    
Borrowings of debt 335 1,275
Repayments of debt (111) (658)
Repurchases of Liberty common stock   (58)
Shares repurchased by subsidiary (594) (535)
Excess tax benefit from stock-based compensation 73 14
Taxes paid in lieu of shares issued for stock-based compensation (4) (16)
Other financing activities, net 13 10
Net cash provided (used) by financing activities (288) 32
Net increase (decrease) in cash and cash equivalents 401 491
Cash and cash equivalents at beginning of period 201 681
Cash and cash equivalents at end of period $ 602 $ 1,172